OXEHEALTH LIMITED

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  +59.2%

  £4,746,746 → £7,556,057

• Cash

  -43.1%

  £3,197,095 → £1,818,955

• Net assets

  -223.7%

  -£1,211,223 → -£3,921,164

• Employees

  -4.2%

  95 → 91

• Operating profit

  +30.2%

  -£6,943,441 → -£4,849,337

• Profit before tax

  +27.9%

  -£7,180,377 → -£5,178,899

• Wages

  +13.7%

  £5,580,372 → £6,347,110

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Consolidated group

Auditor

Corrigan Accountants Limited

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The financial statements have been prepared on a going concern basis which the Directors consider to be appropriate for the following reasons. The Directors have considered the Group's liquidity position. The Group is investor funded and has sufficient funding in place to secure the business beyond the going concern consideration timeframe of 12 months. At 31 December 2024, the Group had £1,818,955 of cash and cash equivalents and net current liabilities of £(6,454,116). As detailed in the post balance sheet events note, a fundraise completed in March 2025 gave rise to an additional £2.1m of capital being invested in the business. Consequently, the Directors are confident that the Group will have sufficient funds to continue to meet its liabilities as they fall due for at least 12 months from the date of approval of the financial statements and therefore have prepared the financial statements on a going concern basis.”

Group structure

1. OXEHEALTH LIMITED · parent
   1. Oxehealth Inc. 100% · USA
   2. Oxehealth AB 100% · Sweden

Significant events

• “Since the end of 2024, the Group has issued a total of 203,839 shares for a gross cash consideration of £3,546,973.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

7

last 12 months

Capital events

10

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.